Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
09/10/1997 | EP0793958A2 Process for preparing a composition containing fenofibrate |
09/10/1997 | EP0793721A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof |
09/10/1997 | EP0793719A2 Rna component of telomerase |
09/10/1997 | EP0793671A1 Phenylsubstituted 4-azasteroid fluoroderivatives |
09/10/1997 | EP0793669A1 L-nucleoside dimer compounds and therapeutic uses |
09/10/1997 | EP0793668A1 Derivatives of carbohydrates and compositions containing them |
09/10/1997 | EP0793667A1 Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them |
09/10/1997 | EP0793665A1 Heterocyclic compounds and their preparation and use |
09/10/1997 | EP0793664A1 Morphine and codeine derivatives for use in therapy |
09/10/1997 | EP0793663A1 (thiophen-2-yl)-piperidin or tetrahydropyridin carboxamides |
09/10/1997 | EP0793662A1 Aminomethyl aryl compounds; dopamine receptor subtype selective ligands |
09/10/1997 | EP0793661A1 Piperazine, piperidine & tetrahydropyridine derivatives useful as 5-ht1 receptor agonists |
09/10/1997 | EP0793660A1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
09/10/1997 | EP0793658A1 Oxazole derivatives as antagonists of alpha-1c adrenergic receptors |
09/10/1997 | EP0793657A1 Microbicidal triazolyl derivatives |
09/10/1997 | EP0793656A1 Novel benzyl pyrimidines |
09/10/1997 | EP0793654A1 Antibacterial dibenzimidazole derivatives |
09/10/1997 | EP0793653A1 Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands |
09/10/1997 | EP0793649A1 18,19-dinor-vitamin d compounds |
09/10/1997 | EP0793648A1 18-nor-vitamin d compounds |
09/10/1997 | EP0793646A1 Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus |
09/10/1997 | EP0793643A1 Matrix metalloprotease inhibitors |
09/10/1997 | EP0793641A1 Metalloproteinase inhibitors |
09/10/1997 | EP0793507A2 Process for the preparation of a pharmacologically active chemical combination |
09/10/1997 | EP0793500A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers |
09/10/1997 | EP0793499A1 Method and composition for reducing tumor development with a combination of a taxane compound and a tellurium and/or selenium compound |
09/10/1997 | EP0793498A1 Bicyclic heterocyclic compounds for the treatment of impotence |
09/10/1997 | EP0793496A2 USE OF HALOGENATED $g(b)-CARBOLINES AS MODEL SUBSTANCES TO PRODUCE NEURODEGENERATIVE DISORDERS |
09/10/1997 | EP0793495A1 Freeze-dried ondansetron compositions |
09/10/1997 | EP0793494A1 2-heterocyclyloxy and thiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
09/10/1997 | EP0793493A1 Method and composition for reducing tumor development with a combination of platinum and tellurium or selenium compounds |
09/10/1997 | EP0793492A1 Treating disorders characterised by excessive cell proliferation with sclareolide |
09/10/1997 | EP0793491A1 Pharmaceutical compositions comprising lycopene |
09/10/1997 | EP0793490A1 Compositions of tocopherol and beta-carotene |
09/10/1997 | EP0793489A1 Compositions for the treatment of skin disorders |
09/10/1997 | EP0793488A1 Increasing fetal hemoglobin levels using carboxylic esters |
09/10/1997 | EP0793487A1 Novel anti-proliferative effects of sodium butyrate |
09/10/1997 | EP0793486A1 cGMP-PDE INHIBITORS FOR THE TREATMENT OF ERECTILE DYSFUNCTION |
09/10/1997 | EP0793483A1 Methods of treating lung disease |
09/10/1997 | EP0793476A1 Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof |
09/10/1997 | EP0734249A4 Novel and improved aminoglycoside formulation for aerosolization |
09/10/1997 | EP0717627A4 Cosmetic compositions |
09/10/1997 | EP0712403B1 Matrix metalloprotease inhibitors |
09/10/1997 | EP0699073A4 Allogeneic and xenogeneic transplantation |
09/10/1997 | EP0689454B1 Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
09/10/1997 | EP0683787B1 4'-o-sulfonyl-anthracycline derivatives |
09/10/1997 | EP0675724B1 Use of dideoxy nucleoside analogues in the treatment of viral infections |
09/10/1997 | EP0674649B1 Antiparasitic agents |
09/10/1997 | EP0664807B1 Quinoxalinedione derivatives as eaa antagonists |
09/10/1997 | EP0664701B1 Taste-masking compositions of ranitidine |
09/10/1997 | EP0644767B1 Veterinary rehydration product |
09/10/1997 | EP0640070B1 Styryl derivatives, their preparation and use as pde-iv inhibitors |
09/10/1997 | EP0625166B1 Sulphated polysaccharides, preparation thereof, pharmaceutical composition and use thereof |
09/10/1997 | EP0625046B1 Pharmaceutical aerosol formulations comprising beclomethasone dipropionate |
09/10/1997 | EP0619304B1 22-oxacholecalciferol derivative and production thereof |
09/10/1997 | EP0586405B1 NOVEL 2H-BENZO[b]PYRANE DERIVATIVES SUBSTITUTED IN THE 4 POSITION BY ARYL OR N-HETEROARYL, PROCESS FOR PRODUCING THEM AND PREPARATIONS CONTAINING THE COMPOUNDS |
09/10/1997 | EP0571520B1 Novel therapeutic use of pycnogenols for the preparation of anti-inflammatory medicaments |
09/10/1997 | EP0566644B1 Method of removing endotoxins |
09/10/1997 | EP0558635B1 Improved matrix metalloprotease inhibitors |
09/10/1997 | EP0544886B1 METHOD OF EXTRACTING SENNOSIDES A, B and A1 |
09/10/1997 | CN1159196A Inhibitors of interleukin-1'beta' converting enzyme |
09/10/1997 | CN1159195A Epimers of (22RS)-N-(1,1,1-trifluoro-2-phenylprop-2-YL)-3-oxo-4-aza-5'alpha'-androst-1-ene-17'beta'-carboxamide |
09/10/1997 | CN1159194A Therapeutic compounds |
09/10/1997 | CN1159193A Compounds useful as antiproliferative agents and GARFT inhibitors |
09/10/1997 | CN1159192A Substituted camptothecin derivatives and process for their preparation |
09/10/1997 | CN1159190A Bioactive acetogenins and derivatives |
09/10/1997 | CN1159187A Heterocyclic-and carbocyclic-substituted benzoic acids and synthesis thereof |
09/10/1997 | CN1159183A BIS-(2-haloethyl) aminophenyl substituted distamycin derivatives as antitumor and antiviral agents |
09/10/1997 | CN1159179A Processes for preparation of (E)-2-fluoromethylene-4-(4-fluorophenyl) butylamine and alkali metal salts of diformylamide |
09/10/1997 | CN1159162A Antithrombotic and non-hemorrhagic heparin-based compositions, method for their preparation and therapeutic applications |
09/10/1997 | CN1159161A Combined hormonal contraception pharmaceutical preparation |
09/10/1997 | CN1159158A Antibacterial oil-in-water emulsions |
09/10/1997 | CN1158855A Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmacueticals |
09/10/1997 | CN1158850A New thiophene compounds, process for their preparation and pharmaceutical compositions containing them |
09/10/1997 | CN1158847A New 4-imidazolidinone compound, process for its preparation and pharmaceutical compositions which contain it |
09/10/1997 | CN1158844A Tertiary amines |
09/10/1997 | CN1158732A Aldehyde-olefin scald medicine liquid |
09/10/1997 | CN1158727A Antidiarrheal |
09/10/1997 | CN1158726A Process for making pharmaceutical formulation containing novel steroid esters |
09/10/1997 | CN1158725A Use of 8,9-dehydroestrone as antioxidant |
09/10/1997 | CN1158724A Veterinary antiparasitic lincture contg. avermectin or invermectin |
09/10/1997 | CN1158723A Preparation and application of Ketang'an oral liquid |
09/10/1997 | CN1035821C Prepn. of 4-deoxy-4-epipodophyllotoxin derivatives |
09/10/1997 | CN1035817C Prepn. of triazolyl-substituted tertiary amino compounds and their salts |
09/10/1997 | CN1035803C Soluble hemostyptic fabric |
09/10/1997 | CN1035801C Microgranular preparation useful in delivery of biologically active materials to intestinal regious of animals |
09/09/1997 | US5665886 Neurokinin receptor antagonists |
09/09/1997 | US5665883 Treatment of pain, inflammation, migraine, emesis |
09/09/1997 | US5665878 Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives |
09/09/1997 | US5665874 Cancer related antigen |
09/09/1997 | US5665873 Inhibits reactivation of herpes virus |
09/09/1997 | US5665780 Reversal of multi-drug resistance by tetraarylethylenes |
09/09/1997 | US5665779 Pharmaceutical composition for inhibiting the infection with AIDS virus |
09/09/1997 | US5665778 Ceramides, process for their preparation and their applications in cosmetics and in dermopharmacy |
09/09/1997 | US5665777 Biphenyl hydroxamate inhibitors of matrix metalloproteinases |
09/09/1997 | US5665776 Mixing a pharmaceutically active first ingredient with a second ingredient |
09/09/1997 | US5665774 Treatment of autoimmune diseases |
09/09/1997 | US5665773 Cloprostenol and fluprostenol analogues and their use to treat glaucoma and ocular hypertension |
09/09/1997 | US5665772 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
09/09/1997 | US5665771 Platinum complexes |